USE OF AGONISTS OF INTEGRIN ALPHA 5 FOR INDUCING THE OSTEOGENIC DIFFERENTIATION OF MESENCHYMAL STEM CELLS
摘要
The invention relates to the use of agonists of integrin alpha for promoting osteoblast differentiation of mesenchymal stem cells. These agonists are useful in particular for enhancing osteogenesis in the treatments of diseases associated with bone loss or insufficient bone formation.
申请公布号
WO2010015938(A3)
申请公布日期
2010.04.22
申请号
WO2009IB06826
申请日期
2009.08.05
申请人
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);UNIVERSITE PARIS DIDEROT - PARIS 7;MARIE, PIERRE;FROMIGUE, OLIVIA;HAMIDOUCHE, ZAHIA
